These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 2576230)

  • 1. Dopamine D-1 and D-2 receptor agonists and antagonists and neuropeptide-induced excessive grooming.
    Van Wimersma Greidanus TB; Maigret C; Torn M; Ronner E; Van der Kracht S; Van der Wee NJ; Versteeg DH
    Eur J Pharmacol; 1989 Dec; 173(2-3):227-31. PubMed ID: 2576230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific D1 and D2 dopamine agonists have synergistic effects in the 6-hydroxydopamine circling model in the rat.
    Rouillard C; Bédard PJ
    Neuropharmacology; 1988 Dec; 27(12):1257-64. PubMed ID: 2907616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ontogeny of locomotor activity and grooming in the young rat: role of dopamine D1 and D2 receptors.
    McDougall SA; Arnold TF; Nonneman AJ
    Eur J Pharmacol; 1990 Sep; 186(2-3):223-30. PubMed ID: 1981185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effects of D-1 and D-2 dopamine receptor agonist and antagonist drugs on basal ganglia [Met5]- and [Leu5]-enkephalin and neurotensin content in the rat.
    Taylor MD; de Ceballos ML; Jenner P; Marsden CD
    Biochem Pharmacol; 1991 May; 41(9):1385-91. PubMed ID: 1673340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of locally applied D-1 and D-2 receptor agonists and antagonists studied with brain dialysis.
    Imperato A; Di Chiara G
    Eur J Pharmacol; 1988 Nov; 156(3):385-93. PubMed ID: 2905668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supersensitivity to a D-1 dopamine receptor agonist and subsensitivity to a D-2 receptor agonist following chronic D-1 receptor blockade.
    Barone P; Tucci I; Parashos SA; Chase TN
    Eur J Pharmacol; 1988 May; 149(3):225-32. PubMed ID: 3261693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of both D-1 and D-2 dopamine receptors may induce catalepsy in mice.
    Zarrindast MR; Habibi-Moini S
    Gen Pharmacol; 1991; 22(6):1023-6. PubMed ID: 1687392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of D-2 mechanisms in the reversal of reserpine hypothermia in the mouse.
    Volterra G; Borsini F; Meli A
    J Pharm Pharmacol; 1988 Sep; 40(9):638-41. PubMed ID: 2907031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugs acting at D-1 and D-2 dopamine receptors induce identical purposeless chewing in rats which can be differentiated by cholinergic manipulation.
    Collins P; Broekkamp CL; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1991; 103(4):503-12. PubMed ID: 1676528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of repeated treatment with imipramine, (+)- and (-)-oxaprotiline on behavioural effects of dopamine D-1 and D-2 agonists.
    Maj J; Papp M; Skuza G; Bigajska K; Zazula M
    J Neural Transm; 1989; 76(1):29-38. PubMed ID: 2565359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different effects of direct and indirect dopamine receptor agonists on immobility time in reserpine-treated mice.
    Zarrindast MR; Minaian A
    Gen Pharmacol; 1991; 22(6):1017-21. PubMed ID: 1687391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of selective actions of dopamine D-1 and D-2 receptor agonists and antagonists on opioid antinociception.
    Rooney KF; Sewell RD
    Eur J Pharmacol; 1989 Sep; 168(3):329-36. PubMed ID: 2573534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D2-receptors mediate hypothermia in mice: ICV and IP effects of agonists and antagonists.
    Nunes JL; Sharif NA; Michel AD; Whiting RL
    Neurochem Res; 1991 Oct; 16(10):1167-74. PubMed ID: 1686637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible role of dopamine D1 receptor in the behavioural supersensitivity to dopamine agonists induced by chronic treatment with antidepressants.
    Serra G; Collu M; D'Aquila PS; De Montis GM; Gessa GL
    Brain Res; 1990 Sep; 527(2):234-43. PubMed ID: 1979237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in motor activities induced by microinjections of the selective dopamine agonists LY 171555, quinpirole hydrochloride, and SK&F 38393 into the habenula nucleus.
    Thornton EW; Evans JA; Wickens A
    Pharmacol Biochem Behav; 1987 Mar; 26(3):643-6. PubMed ID: 3495009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats.
    Arnt J; Hyttel J; Perregaard J
    Eur J Pharmacol; 1987 Jan; 133(2):137-45. PubMed ID: 2949991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The induction of grooming and vacuous chewing by a series of selective D-1 dopamine receptor agonists: two directions of D-1:D-2 interaction.
    Murray AM; Waddington JL
    Eur J Pharmacol; 1989 Feb; 160(3):377-84. PubMed ID: 2565818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between dopamine D1 and D2 receptors in the model of thyrotropin-releasing hormone (TRH)-induced behaviour in rabbits.
    Popoli P; Caporali MG; Scotti de Carolis A
    Eur J Pharmacol; 1991 Aug; 201(1):11-6. PubMed ID: 1686587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of a delta opioid receptor agonist but not a mu opioid receptor agonist with the D1-selective dopamine receptor agonist SKF 38393 markedly potentiates different behaviors in mice.
    Toyoshi T; Ukai M; Kameyama T
    Eur J Pharmacol; 1992 Mar; 213(1):25-30. PubMed ID: 1354161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responses to selective D-1 and D-2 agonists after repeated treatment with selective D-1 and D-2 antagonists.
    Gandolfi O; Dall'olio R; Vaccheri A; Roncada P; Montanaro N
    Pharmacol Biochem Behav; 1988 Jun; 30(2):463-9. PubMed ID: 3262877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.